Back to Search
SHANNON ZULLO, MD
MD
Dermatology Physician
NPI: 1053936799IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
MD491482(PA)
Education
UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE
Class of 2020
Research & Publications (18)
Association of cholesterol oxidation and abnormalities in fatty acid metabolism in cystic fibrosis.
PMID 19587087·Am J Clin Nutr·2009
8-other
Use of continuous subcutaneous insulin infusion in patients with cystic fibrosis related diabetes: three case reports.
PMID 16973423·J Cyst Fibros·2007
5-case
Factors that might affect the allotopic replacement of a damaged mitochondrial DNA-encoded protein.
PMID 16706640·Rejuvenation Res·2006
6-review
Stable transformation of CHO Cells and human NARP cybrids confers oligomycin resistance (oli(r)) following transfer of a mitochondrial DNA-encoded oli(r) ATPase6 gene to the nuclear genome: a model system for mtDNA gene therapy.
PMID 15798371·Rejuvenation Res·2005
7-preclinical
Standards requirements for systems biology approaches to health care: mitochondrial proteomics.
PMID 16120355·Mitochondrion·2004
8-other
Quantification of total mitochondrial DNA and the 4977-bp common deletion in Pearson's syndrome lymphoblasts using a fluorogenic 5'-nuclease (TaqMan) real-time polymerase chain reaction assay and plasmid external calibration standards.
PMID 16120337·Mitochondrion·2003
8-other
A maternal line study investigating the 4977-bp mitochondrial DNA deletion.
PMID 12742534·Exp Gerontol·2003
8-other
In vitro evidence of inhibition of mitochondrial protease processing by HIV-1 protease inhibitors in yeast: a possible contribution to lipodystrophy syndrome.
PMID 16120303·Mitochondrion·2002
8-other
In situ PCR of the common human mtDNA deletion. Is it related to apoptosis?
PMID 12013790·Methods Mol Biol·2002
8-other
Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12.
PMID 12296646·J Neurosurg·2002
7-preclinical
Nanotechnology: Emerging Developments and Early Detection of Cancer. A two-day workshop sponsored by the National Cancer Institute and the National Institute of Standards and Technology, August 30-31 2001, on the National Institute of Standards and Technology Campus, Gaithersburg, MD, USA.
PMID 12590168·Dis Markers·2002
6-review
Gene therapy of mitochondrial DNA mutations: a brief, biased history of allotopic expression in mammalian cells.
PMID 11641822·Semin Neurol·2001
6-review
Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.
PMID 11235953·J Neurosurg·2001
7-preclinical
Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus.
PMID 11687903·Cancer Gene Ther·2001
7-preclinical
Dopamine induces cell death, lipid peroxidation and DNA base damage in a catecholaminergic cell line derived from the central nervous system.
PMID 12835100·Neurotox Res·2000
8-other
Genomic structure of murine mitochondrial DNA polymerase-gamma.
PMID 11058962·DNA Cell Biol·2000
7-preclinical
Evaluation of recombinant alphaviruses as vectors in gene therapy.
PMID 10757020·Gene Ther·2000
4-observational
Induction of a therapeutic antitumor immunological response by intratumoral injection of genetically engineered Semliki Forest virus to produce interleukin-12.
PMID 16817690·Neurosurg Focus·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3151 WALBERT AVE STE 301
ALLENTOWN, PA 18104 - Phone
- (484) 503-7546
Quick Facts
- NPI
- 1053936799
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 6
- Publications
- 18
Are you this provider?
Claim Your Profile